Clinical Trial Update: Expanded Access to Gallium Maltolate (GaM)

View source ↗

Summary

Expanded access to Gallium maltolate (GaM) for glioblastoma is no longer available.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Glioblastoma

Drugs mentioned

• Gallium maltolate (gallium maltolate)

Snippet

Sponsor: Imaging Biometrics, LLC | Conditions: Glioblastoma, Refractory Glioblastoma | Status: NO_LONGER_AVAILABLE